ERS Genomics and chemical company plc have signed a non - exclusive licensing agreement which will provide researchers with access to ERS ' CRISPR - Cas9 genome editing technique . The technology will be used in the engineering of yeast and fungi as ingredients for human and animal health , food and drink , plus other industrial applications .
ERS Genomics and chemical specialist Evolva have signed a non-exclusive licence agreement which will provide Evolva with access to ERS' CRISPR-Cas9 genome editing technique. The technology will be used in the engineering of yeast and fungi as ingredients for human and animal health, food and drink, plus other industrial uses.